Application of Design of Experiments using JMP to Develop a Universal

Slides:



Advertisements
Similar presentations
Enzyme Linked Immunosorbent Assay
Advertisements

Design of Experiments Lecture I
Aptamers in the Real World Development and Applications NeoVentures Biotechnology Inc. Aptamers Applied1.
Fractional Factorial Designs of Experiments
In the name of God. Summer School Influenza Unit, Pasteur Institute of Iran summer 2012.
ELISA Enzyme Linked Immunosorbent Assay. Definitions  Antibodies (also known as immunoglobulins abbreviated Ig) are gamma globulin proteins that are.
1 Lecture: Forensic Serology - Immunoassays Antibody/Antigen reaction provides the means of generating a measurable result. “Immuno” refers to an immune.
Chemical Analysis Qualitative Analysis Quantitative Analysis Determination “Analyze” a paint sample for lead “Determine” lead in a paint sample.
L Berkley Davis Copyright 2009 MER301: Engineering Reliability Lecture 14 1 MER301: Engineering Reliability LECTURE 14: Chapter 7: Design of Engineering.
Chapter 28 Design of Experiments (DOE). Objectives Define basic design of experiments (DOE) terminology. Apply DOE principles. Plan, organize, and evaluate.
Enzyme-linked Immunosorbent Assay
(Enzyme Linked Immunosorbent Assay)
Simoa Accelerator Laboratory
Annex I: Methods & Tools prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY.
DOE – An Effective Tool for Experimental Research
Mapping protein-DNA interactions by ChIP-seq Zsolt Szilagyi Institute of Biomedicine.
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Enzyme Linked Immunosorbent Assay (ELISA). ELISA Enzyme Linked Immunosorbent Assay (ELISA) Term Was Coined By Engvall and Pearlmann in 1971 Different.
Enzyme-Linked Immunosorbent Assay [ELISA] BCH 462[practical] Lab#5.
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Immunoassays 1.
1 Immunoassay Testing Forensic Toxicology. 2 Introduction Antibody/Antigen reaction provides the means of generating a measurable result. “Immuno” refers.
The Enzyme Linked Immunosorbent Assay (ELISA).. Capture ELISAs Antigen Capture: In this, more specific approach, a capturing Ab is adsorbed onto the solid.
ANALYSIS OF VARIANCE (ANOVA) BCT 2053 CHAPTER 5. CONTENT 5.1 Introduction to ANOVA 5.2 One-Way ANOVA 5.3 Two-Way ANOVA.
MSE-415: B. Hawrylo Chapter 13 – Robust Design What is robust design/process/product?: A robust product (process) is one that performs as intended even.
BioChip Ventures Division a 3-Dimensional Microarray Substrate.
Author: Cheng-Chi Wang, Chi-Huey Wong
ELISA Nada Mohamed Ahmed , MD, MT (ASCP)i.
DETECTION OF RICIN IN FOOD MATRICES USING ELECTROCHEMILUMINESCENCE (ECL)-BASED TECHNOLOGY Eric A.E. Garber 1, Thomas W. O’Brien 2, George Sigal 3 1 Division.
1 Tom Edgar’s Contribution to Model Reduction as an introduction to Global Sensitivity Analysis Procedure Accounting for Effect of Available Experimental.
Top right corner for field-mark, customer or partner logotypes. See Best practice for example. Slide title 40 pt Slide subtitle 24 pt Text 24 pt Bullets.
Bioassay Optimization and Robustness Using Design of Experiments Methodology 2015 NBC, San Francisco June 8, 2015 Kevin Guo.
Enzyme Linked Immunosorbent Assay
1 A latent information function to extend domain attributes to improve the accuracy of small-data-set forecasting Reporter : Zhao-Wei Luo Che-Jung Chang,Der-Chiang.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Designing Drugs Virtually P14D461P - Arni B. Hj. Morshidi P14D389P - Anisah Bt Ismail P14D397P - Syarifah Rohaya Bt Wan Idris P14D394P - Dayang Adelina.
The ELISA Enzyme-Linked ImmunoSorbent Assay A highly specific and sensitive procedure allowing evaluation of multiple agents for a single serum dilution.
A Sandwich DNA Model for Rapid and Sensitive Detection of NSCLC Utilizing the Magnetic Modulation Biosensing System Saar Ashri The Open University Optical.
2015 JMP Discovery Summit, San Diego
Multiplex analysis of cytokines Russell Garland KWS BioTest
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Enzyme Linked Immunosorbent Assay
Enzyme Linked Immunosorbent Assay (ELISA)
Immunoassays are tests that take advantage of the specificity of antibodies to their protein epitotes. Qualitative example: pregnancy test kits, HIV.
ELISA for mAb detection and Quantification
Overview Modern chip designs have multiple IP components with different process, voltage, temperature sensitivities Optimizing mix to different customer.
Robert Anderson SAS JMP
Absorbance: Enzyme Linked Immunosorbent Assays (ELISA)
Design of Experiments (DOE)
KJ Hansen, JK Simons, TA Peterson
Enzyme Linked Immunosorbent Assay
Definitive Screening Design on IDBV
Synthesis and Evaluation of anti-Nonspecific Binding Coating in Microfluidic Devices for ELISA Bioassays Melissa J. Gelwicks.
Introduction to ELISA ELISA – short for enzyme-linked immunospecific assay A technique that measures the amount of a specific protein in a solution.
Ellie M. Papoutsakis, Rachel S. Riley, and Emily S. Day
Enzyme-Linked Immunosorbent Assay [ELISA]
Innovative approach for the quantitative analysis of therapeutic monoclonal antibody (mAb), and simultaneous characterization of Anti-Drug Antibodies (ADA)
MANA 4328 Dr. Jeanne Michalski
Proteon Scientists from Creative Biolabs are willing to provide custom antibody affinity measurement using ProteOn system. The system is a surface plasmon.
Practical clinical chemistry
IE-432 Design Of Industrial Experiments
Challenges of Bridging Studies in Biomarker Driven Clinical Trials
Introduction to ELISA ELISA – short for enzyme-linked immunospecific assay A technique that measures the amount of a specific protein in a solution.
Nachiket Shembekar, Hongxing Hu, David Eustace, Christoph A. Merten 
Fine mapping assay with a G6 peptide library identifies two epitopes recognized by the anti-P39 antibody. Fine mapping assay with a G6 peptide library.
Measurement of Immune function:
Samsung Austin Semiconductor
Enzyme Linked  Immuno sorbent  Assay  
DESIGN OF EXPERIMENTS by R. C. Baker
The Systematic Production of Cells for Cell Therapies
Yingze Wang and Shi-Kuo Chang University of Pittsburgh
Presentation transcript:

Application of Design of Experiments using JMP to Develop a Universal Quantitative Method for Preclinical Pharmacokinetic Support Alok Rathi, Carina Carter, Qiang Qu, Jim McNally, Theresa Goletz. EMD Serono Research and Development Institute, Inc., Billerica, MA Introduction Screening Reagents A plate map was carefully designed by grouping different factors based on the run information table for better execution. Only three samples were needed for each run : HQC, LQC and a Blank sample. The concentration of the HQC and LQC samples were chosen based on the targeted sensitivity and the range of quantification. The data from the plate was then used to have the statistical analysis using JMP. Pharmacokinetic (PK) assays that measure the drug concentrations in a sample, are essential to the non-clinical safety data package. PK assays for large molecules require the generation of reagents specific to the biotherapeutic. A universal quantitative assay that recognizes an epitope of a given framework common to various biotherapeutics, for example the common human IgG framework, would improve efficiency by reducing reagent generation costs, minimizing resource utilization and shortening timelines. Multiple commercially available anti-human IgG antibodies, which specifically bind to any molecule containing the human IgG framework epitope, were screened for their binding affinity to the reference human IgG. Instead of using a one factor at a time approach, a more efficient design of experiment (DOE) approach was utilized using JMP to optimize assay parameters that achieve targeted responses. Multitude of factors were tested simultaneously, such as assay buffers, range of minimal required dilutions and concentrations for capture and detection reagents. This significantly reduced the number of experiments that would be needed to test each factor separately, thereby considerably shortening the assay development time. The DOE approach using JMP allowed for a rapid development and qualification of a universal assay in multiple species. From a panel of commercially available anti-human IgG antibodies, a pair was chosen, based on the binding affinities of the antibodies to the IgG molecule, determined by Octet, and which gave higher sensitivity and a broader dynamic range by testing in a checkerboard ELISA format on the Meso Scale Discovery (MSD) platform using default conditions. Image 5: Table with each run information Image 3: Checkerboard ELISA run on MSD platform result Image 6: Plate map designed based on the run information table Image 2: Pairing experiment on the Octet Results Design of Experiment setup (DOE) in JMP After data input for each run in the run information table, the data was analyzed by selecting the model specifications, and the prediction profiler was obtained. The prediction profiler finds the factor settings that maximize the predicted yield. The change in certain factors, as can be analyzed by movement of the red dotted line in the profiler, would significantly affect the assay responses. Desirability is maximized for each response, and the most balanced desirability is selected based on analytical understanding of the assay. The conditions that were determined by performing the DOE in a single run were: Coating Concentration of 5 µg/mL. MRD of 1:25. Detector Concentration of 0.5 µg/mL. BGG assay buffer. Objective DOE – Full Factorial Design approach was utilized to optimize assay development decisions on multiple factors simultaneously. Factors tested: Capture concentration Detector concentration Minimal Required Dilution (MRD) Assay buffers Responses High Quality Control (HQC) / Low Quality Control (LQC) Low Quality Control (LQC) / Blank samples Maximizing the signal / noise ratio of the responses would result in better sensitivity, lower background and a broader dynamic range of quantification. A ligand binding enzyme linked immunosorbent assay (ELISA) experimental design usually requires the need to identify the capture and detector antibodies, and then optimize the conditions of these critical reagents, so that they interact with the drug molecule, to achieve the desired results. Image 1: A standard sandwich ELISA method The optimization process includes testing multiple parameters that determine the assay outcome and is mostly based on a trail and error process using previous knowledge and experience. The design of experiments (DOE) approach provides a systemic method to determine the relationship between multiple factors affecting the experiment and their effect on the response for that experiment. The DOE approach was used to evaluate which assay inputs (i.e. buffers, concentrations, dilutions etc.) had a significant impact on the process output, and what the target level of those inputs should be to achieve the desired output. Testing multiple factors simultaneously increases efficiency and decreases the time and resources required to complete assay development. Image 4: Full Factorial DOE setump in JMP 13.0.0 Image 7: Prediction Profiler Conclusions The DOE approach allowed for the rapid development of the universal assay with a broad dynamic range, which can be applied to several drug molecules containing the human IgG framework in multiple non-clinical species. Multiple factors were tested simultaneously using DOE, which allowed for determining the optimum conditions for the experiment in a short period of time, thereby significantly helping to shorten development timelines and minimizing resource utilization. DOE Execution Table with run information was generated after DOE design was setup. 2 responses for 4 factors 2x2x2x2 = 16 total runs.

A standard sandwich ELISA method Image 1: A standard sandwich ELISA method

Image 2: Pairing experiment on the Octet to determine the antibodies with higher binding affinity to the human IgG Binding affinity of the anti-human IgG antibodies to the human IgG were determined using octet, and the high binding pairs were selected to test on a plate based MSD platform format.

Checkerboard ELISA run on MSD platform to determine antibody pairs Image 3: Checkerboard ELISA run on MSD platform to determine antibody pairs Factors being considered to determining suitable capture and detector: High S/N ratio Low background signal Title of Presentation | DD.MM.YYYY

Full Factorial DOE setup in JMP 13.0.0 Image 4: Full Factorial DOE setup in JMP 13.0.0 A full factorial design was setup to determine the optimum conditions for the assay. The factors being tested were: Coating concentration (Continuous – concentrations tested from 2µg/mL to 5µg/mL) Detector concentration (Continuous – concentrations tested from 0.5µg/mL to 1µg/mL) MRD (Continuous – dilutions tested from 1:10 to 1:40) Assay buffers (Categorical – factors tested in 2 different assay buffers – buffer containing Bovine Gamma Globulin (BGG) and commercial Superblock buffer) The response desired were: Maximum signal/noise ratio between High Quality Control (QC) / Low QC and Low QC / Blank samples Maximizing the response would result in better assay sensitivity and would give a lower background and a broad range of quantification Title of Presentation | DD.MM.YYYY

Table with run information based on the design setup in JMP 13.0.0 Image 5: Table with run information based on the design setup in JMP 13.0.0 The full factorial design setup required 16 runs to execute the DOE. Various combinations for all the factors were to be tested, for JMP to be able to provide a model for the range of values of the factors, to achieve the desired responses. The runs can be grouped together for any one factor for convenience in experiment execution. Title of Presentation | DD.MM.YYYY

Plate map designe based on the run information table in JMP Image 6: Plate map designe based on the run information table in JMP The plate map being carefully designed by grouping the capture concentrations together in the run information table in JMP design setup. Only three samples were needed for each run to calculate the required responses set in JMP. The concentrations of the high and the low quality control samples (HQC and LQC) were chosen based on the targeted sensitivity and range of quantification desired.

Image 7: Prediction Profiler – to determine the factor settings that maximize the predicted yield. The profiler finds the factor settings that maximize the predicted yield. The change in certain factors, as can be analyzed by movement of the red dotted line in the profiler, would significantly affect the assay responses. Desirability is maximized for each response, and the most balanced desirability is selected based on analytical understanding of the assay. The conditions that were determined by performing the DOE in a single run were: Coating concentration is 5 µg/mL MRD is 1:25 Detector concentration is 0.5 µg/mL Assay buffer is buffer containing Bovine Gamma Globulin (BGG)